1. Normal-Weight Obesity: Implications for Cardiovascular Health

   • Nathalie Jean
   • Virend K. Somers
   • Francisco Lopez-Jimenez

   Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 24 October 2014 Article: 464

   

2. Ivabradine, Coronary Heart Disease, and Heart Failure: Time for Reappraisal

   • Tomáš Štulc
   • Richard Češka

   Invited Commentary 10 October 2014 Article: 463

3. Interaction Between Pro12Ala Polymorphism of PPARγ2 and Diet on Adiposity Phenotypes

   • Emanuela Lapice
   • Olga Vaccaro

   Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 24 October 2014 Article: 462

4. Surgical Versus Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease

   • Piroze M. Davierwala
   • Freidrich W. Mohr

   Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 26 October 2014 Article: 461

5. The Role of Lifestyle Change for Prevention of Cardiovascular Disease in Diabetes

   • Lisa R. Staimez
   • Mary Beth Weber
   • Edward W. Gregg

   Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 04 November 2014 Article: 460

6. Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease

   • Mark Shipeng Yu
   • David A. Folt
   • Christopher J. Cooper

   Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 10 October 2014 Article: 459

7. Statins, Glycemia, and Diabetes Mellitus: Another Point of View

   • Tomáš Štulc
   • Richard Češka

   Invited Commentary 07 October 2014 Article: 458

8. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes

   • Craig A. Johnston
   • Jennette P. Moreno
   • John P. Foreyt

   Nutrition (JP Foreyt, Section Editor) 07 October 2014 Article: 457